News

Elevation Oncology Highlights Upcoming H.C. Wainwright Conference

Elevation Oncology Highlights Upcoming H.C. Wainwright Conference

Elevation Oncology to Shine at Investment Conference

Elevation Oncology, Inc. (NASDAQ: ELEV) is set to highlight its innovative advancements in oncology at the prestigious H.C. Wainwright 26th Annual Global Investment Conference. This important event brings together key investors and industry leaders who are interested in groundbreaking healthcare solutions that tackle some of the most urgent challenges in the field.

Conference Details

Joseph J. Ferra, the Chief Executive Officer of Elevation Oncology, will engage in a fireside chat addressing vital topics related to the future of cancer treatment. This presentation is scheduled for an upcoming Tuesday at 11:30 am ET. Investors and stakeholders looking for insights can anticipate valuable discussions about Elevation’s cutting-edge therapies.

Event Accessibility

The event will be available through a live webcast, making it easy for those interested in Elevation Oncology’s initiatives to participate. Additionally, a replay will be accessible for anyone who cannot attend live, providing a great opportunity for information sharing and engagement.

Webcast Details

To watch the event, viewers can visit the Company's Investor Relations website, where the webcast will be hosted. Staying informed about these developments is essential for anyone following Elevation Oncology's progress in cancer therapy innovation.

Elevation Oncology's Mission and Focus

Elevation Oncology is dedicated to pioneering selective cancer therapies that meet patient needs across a range of solid tumors. The company is particularly focused on developing novel antibody-drug conjugates (ADCs) to address significant medical areas that are currently underserved.

Innovative Pipeline

The company is advancing a distinctive pipeline that targets clinically validated areas in oncology, specifically focusing on Claudin 18.2 and HER3, which are relevant in various cancers. The lead candidate, EO-3021, is gaining attention as it is designed to be a best-in-class ADC.

Current Trials and Future Prospects

EO-3021 is currently being evaluated in a Phase 1 trial involving patients diagnosed with advanced, unresectable, or metastatic solid tumors likely to express Claudin 18.2, including gastric and pancreatic cancers. Exciting developments are anticipated as the company prepares to announce a development candidate targeting HER3 in 2024.

Broader Impact of Elevation Oncology

With a mission focused on benefiting patients, Elevation Oncology is committed to transforming the landscape of oncology. The company’s innovative strategies have the potential to significantly improve treatment outcomes for patients facing some of the most challenging cancers.

Ongoing Commitment to Research

Research and development are at the heart of Elevation's operations. By continually investing in their ADC platform and committing to clinical validation, they remain leaders in oncology innovation. Elevation’s efforts aim not only to enhance medication efficacy but also to contribute significantly to the overall understanding and management of cancer treatment.

Engagement with the Community

Elevation Oncology's participation in conferences like the H.C. Wainwright event helps to boost its visibility. By engaging with investors, the company fosters essential partnerships for growth, shaping the future of oncology. For more information about Elevation and its advancements, visitors can explore their official website at www.ElevationOncology.com.

Investor and Media Contact Information

If you have inquiries related to investor relations or media requests, please contact Hannah Deresiewicz, EVP and Managing Director at Precision AQ, using the following details:

Phone: 212-362-1200
Email: [email protected]

Frequently Asked Questions

What is the main focus of Elevation Oncology?

Elevation Oncology is dedicated to developing selective cancer therapies that target various solid tumors, addressing significant unmet medical needs.

When will Joseph J. Ferra be speaking?

Joseph J. Ferra will be speaking during a fireside chat on Tuesday at 11:30 am ET at the H.C. Wainwright Conference.

How can I watch the presentation live?

The presentation will be available through a live webcast on the Company's Investor Relations website.

What is EO-3021?

EO-3021 is Elevation Oncology's lead ADC candidate aimed at Claudin 18.2, which is currently being evaluated in Phase 1 trials.

What is next for Elevation Oncology?

Elevation Oncology is planning to nominate a development candidate for a HER3-targeting ADC in 2024, further expanding their innovative pipeline.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Crucial Insights for South GA Home Insurance Choices

Updated Category News Views 7

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Continue Reading
MiniCo's New Desk: A Game Changer for E&S Market

Updated Category News Views 2

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Continue Reading
Concrete Pipe: Foundation of Modern Infrastructure

Updated Category News Views 5

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners

Updated Category News Views 6

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Updated Category News Views 2

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Continue Reading
Medicare Payment Proposal Faces Doctor Backlash in D.C.

Updated Category News Views 5

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

Continue Reading
Local Expertise in Real Estate: Key to Success?

Updated Category News Views 5

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Updated Category News Views 4

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Continue Reading
Nelson-Jameson Boosts Cold Storage in California Move

Updated Category News Views 3

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

Continue Reading
Athlete Threats: Public Info Fuels Security Risks

Updated Category News Views 2

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Continue Reading

Top 5 Most Recently Viewed Articles

Sage Therapeutics Faces Legal Action Over Securities Violations

Updated Category News Views 107

Class Action Lawsuit Filed Against Sage Therapeutics Sage Therapeutics, Inc. is currently facing a class action lawsuit that raises serious concerns for its investors. This legal challenge centers on alleged violations of the Securities Exchange Act, which could have significant consequences for those who own shares in the company. Key Information for Investors If you...

Continue Reading
Celebrating Exceptional Volunteers: Junior Achievement Honors 12

Updated Category News Views 250

Celebrating the Volunteers of Junior Achievement Junior Achievement of USA (JA) has recently announced its selection of 12 remarkable volunteers for the prestigious JA Gold Leadership Award. These individuals have been chosen from a remarkable pool of over 150,000 volunteers nationwide. This award is a testament to their dedication and exceptional commitment to enhancing...

Continue Reading
Anju Showcases Revolutionary MA Knowledge at DIA MICC 2024

Updated Category News Views 310

Explore Anju's Innovative MA Knowledge at DIA MICC 2024 Anju, a leader in the life sciences software industry, is excited to showcase its offerings at the upcoming DIA Medical Information & Communications Conference. This important event, aimed at professionals working with medical information, is just around the corner. What to Look Forward to with MA Knowledge At the...

Continue Reading
The Oncology Institute Earnings Release and Growth Insights

Updated Category News Views 124

The Oncology Institute Shares Upcoming Earnings Release Plans In a significant announcement, The Oncology Institute, Inc. (NASDAQ: TOI) revealed its strategy for releasing first quarter financial results. This gathering is especially crucial for stakeholders and interested parties within the oncology sector. Earnings Release and Conference Call Details The financial...

Continue Reading
Centogene's Extraordinary Meeting Marks Key Company Decisions

Updated Category News Views 203

Exciting Developments from Centogene's Extraordinary General Meeting Centogene N.V. (OTC: CNTGF) has recently celebrated a notable progress point in the company’s journey during its remarkable Extraordinary General Meeting. With a significant representation of 57.16% of the Company’s issued share capital, shareholders rallied behind all proposed resolutions. Most...

Continue Reading